Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Evidence for a multiple sclerosis epidemic?
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
Programming Hippocampal Neural Stem/Progenitor Cells into Oligodendrocytes Enhances Remyelination in the Adult Brain after Injury.
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Colour vision impairment is associated with disease severity in multiple sclerosis.
Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Supporting work for people with multiple sclerosis.
Emerging role of interleukin-22 in autoimmune diseases.
[Multiple sclerosis.]
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Pages
« first
‹ previous
…
315
316
317
318
319
320
321
322
323
…
next ›
last »